Literature DB >> 10037032

Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma.

Y Hayami1, H Komatsu, S Iida, A Utsunomiya, S Hanada, X J Hua, N Huiping, S Harada, K Tsuboi, S Banno, A Wakita, T Kato, R Ueda.   

Abstract

Microsatellite instability (MSI) represents a replication error resulting from the dysfunction of mismatch repair gene products. In this study, MSI was analyzed in 18 patients with various subtypes of adult T cell leukemia/lymphoma (ATL/L). Using six different microsatellite loci, we defined MSI as positive when replication errors were observed in at least two loci. The MSI was positive in four cases (22.2%)with acute type ATL, who tended to show more prognostically unfavorable factors and shorter overall survival. These results suggest that genomic instability may be associated with tumor progression rather than the development of ATL/L itself. In addition, the presence of the MSI at initial presentation could appear to warrant consideration as an additional prognostically unfavorable factor.

Entities:  

Mesh:

Year:  1999        PMID: 10037032     DOI: 10.3109/10428199909167395

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Authors:  S Okazaki; R Moriuchi; N Yosizuka; K Sugahara; T Maeda; I Jinnai; M Tomonaga; S Kamihira; S Katamine
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

Review 2.  Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia.

Authors:  Christophe Nicot
Journal:  J Oncol       Date:  2015-06-10       Impact factor: 4.375

3.  Microsatellite alterations are also present in the less aggressive types of adult T-cell leukemia-lymphoma.

Authors:  Marcelo Magalhães; Pedro D Oliveira; Achiléa L Bittencourt; Lourdes Farre
Journal:  PLoS Negl Trop Dis       Date:  2015-01-15

4.  A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients.

Authors:  Kaname Miyashita; Kei Fujii; Kenichi Taguchi; Mototsugu Shimokawa; Mitsuaki A Yoshida; Yasunobu Abe; Jun Okamura; Shinya Oda; Naokuni Uike
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-25       Impact factor: 4.553

Review 5.  Human T-cell lymphotropic-I-associated leukemia/lymphoma.

Authors:  R S Siegel; R B Gartenhaus; T M Kuzel
Journal:  Curr Treat Options Oncol       Date:  2001-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.